Ann Levin

1.2k total citations
46 papers, 819 citations indexed

About

Ann Levin is a scholar working on Health, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ann Levin has authored 46 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Health, 14 papers in Epidemiology and 13 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ann Levin's work include Vaccine Coverage and Hesitancy (25 papers), Global Maternal and Child Health (13 papers) and COVID-19 epidemiological studies (11 papers). Ann Levin is often cited by papers focused on Vaccine Coverage and Hesitancy (25 papers), Global Maternal and Child Health (13 papers) and COVID-19 epidemiological studies (11 papers). Ann Levin collaborates with scholars based in United States, Switzerland and United Kingdom. Ann Levin's co-authors include Miloud Kaddar, Raymond Hutubessy, Joseph B. Babigumira, Susan A. Wang, Carol Levin, Vivien Tsu, Brian Maskery, Colleen Burgess, Young‐Eun Kim and Vittal Mogasale and has published in prestigious journals such as The Lancet, PLoS ONE and Social Science & Medicine.

In The Last Decade

Ann Levin

44 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann Levin United States 17 323 283 247 167 102 46 819
Jos Vandelaer United States 15 411 1.3× 309 1.1× 193 0.8× 199 1.2× 65 0.6× 21 1.0k
Momodou Jasseh Gambia 21 197 0.6× 198 0.7× 377 1.5× 203 1.2× 123 1.2× 41 991
Jessica Shearer United States 18 315 1.0× 191 0.7× 515 2.1× 120 0.7× 267 2.6× 50 1.1k
Robert Steinglass United States 16 565 1.7× 312 1.1× 201 0.8× 292 1.7× 90 0.9× 36 959
Naveen Thacker India 12 164 0.5× 139 0.5× 187 0.8× 149 0.9× 80 0.8× 47 594
Peter M. Hansen Switzerland 12 227 0.7× 113 0.4× 327 1.3× 98 0.6× 185 1.8× 23 636
Tove K. Ryman United States 17 812 2.5× 439 1.6× 339 1.4× 254 1.5× 148 1.5× 37 1.1k
Chutima Suraratdecha United States 19 201 0.6× 177 0.6× 159 0.6× 228 1.4× 212 2.1× 36 730
Logan Brenzel United States 21 846 2.6× 336 1.2× 339 1.4× 425 2.5× 135 1.3× 62 1.3k
Sarah Wood Pallas United States 14 158 0.5× 144 0.5× 268 1.1× 131 0.8× 226 2.2× 38 719

Countries citing papers authored by Ann Levin

Since Specialization
Citations

This map shows the geographic impact of Ann Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Levin more than expected).

Fields of papers citing papers by Ann Levin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Levin. The network helps show where Ann Levin may publish in the future.

Co-authorship network of co-authors of Ann Levin

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Levin. A scholar is included among the top collaborators of Ann Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Levin. Ann Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levin, Ann, Karene Hoi Ting Yeung, & Raymond Hutubessy. (2024). Systematic review of cost projections of new vaccine introduction. Vaccine. 42(5). 1042–1050. 2 indexed citations
2.
Levin, Ann, et al.. (2023). Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries. BMJ Global Health. 8(7). e011526–e011526. 7 indexed citations
3.
Levin, Ann, Logan Brenzel, Ulla Griffiths, et al.. (2022). WHO-led consensus statement on vaccine delivery costing: process, methods, and findings. BMC Medicine. 20(1). 88–88. 14 indexed citations
5.
Levin, Ann, et al.. (2021). Costing electronic private sector malaria surveillance in the Greater Mekong Subregion. Malaria Journal. 20(1). 192–192. 5 indexed citations
6.
Baral, Ranju, Ann Levin, Chris Odero, et al.. (2021). Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries. PLoS ONE. 16(1). e0244995–e0244995. 16 indexed citations
8.
Pallas, Sarah Wood, et al.. (2019). Program cost analysis of influenza vaccination of health care workers in Albania. Vaccine. 38(2). 220–227. 6 indexed citations
9.
Khan, Ashraful Islam, Ann Levin, Dennis L. Chao, et al.. (2018). The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: A disease modeling and economic analysis. PLoS neglected tropical diseases. 12(10). e0006652–e0006652. 23 indexed citations
10.
Pecenka, Clint, Ann Levin, Philipp Lambach, et al.. (2017). Maternal influenza immunization in Malawi: Piloting a maternal influenza immunization program costing tool by examining a prospective program. PLoS ONE. 12(12). e0190006–e0190006. 14 indexed citations
11.
Levin, Ann, Susan A. Wang, Carol Levin, Vivien Tsu, & Raymond Hutubessy. (2014). Costs of Introducing and Delivering HPV Vaccines in Low and Lower Middle Income Countries: Inputs for GAVI Policy on Introduction Grant Support to Countries. PLoS ONE. 9(6). e101114–e101114. 70 indexed citations
12.
Babigumira, Joseph B., Ian G. Morgan, & Ann Levin. (2013). Health economics of rubella: a systematic review to assess the value of rubella vaccination. BMC Public Health. 13(1). 406–406. 27 indexed citations
13.
Maskery, Brian, Denise DeRoeck, Ann Levin, et al.. (2013). Strategy, Demand, Management, and Costs of an International Cholera Vaccine Stockpile. The Journal of Infectious Diseases. 208(suppl_1). S15–S22. 16 indexed citations
14.
Jit, Mark, Carol Levin, Marc Brisson, et al.. (2013). Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts. BMC Medicine. 11(1). 23–23. 25 indexed citations
15.
Levin, Ann, Colleen Burgess, Louis P. Garrison, et al.. (2011). Global Eradication of Measles: An Epidemiologic and Economic Evaluation. The Journal of Infectious Diseases. 204(Supplement 1). S98–S106. 63 indexed citations
16.
Babigumira, Joseph B., Ann Levin, Colleen Burgess, et al.. (2011). Assessing the Cost-Effectiveness of Measles Elimination in Uganda: Local Impact of a Global Eradication Program. The Journal of Infectious Diseases. 204(suppl_1). S116–S123. 20 indexed citations
19.
Levin, Ann, et al.. (1999). Cost-effectiveness of family planning and maternal health service delivery strategies in rural Bangladesh. The International Journal of Health Planning and Management. 14(3). 219–233. 15 indexed citations
20.
Levin, Ann, et al.. (1999). Effect of price and access on contraceptive use. Social Science & Medicine. 49(1). 1–16. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026